XERIS BIOPHARMA HOLDINGS, INC. (XERS) /
The revenue of XERIS BIOPHARMA HOLDINGS, INC. over the past 6 years
Chart XERIS BIOPHARMA HOLDINGS, INC.: revenue, fiscal 2020–2025 Open the chart →XERIS BIOPHARMA HOLDINGS, INC. reported revenue of $291.85M in fiscal 2025, the latest fiscal year on file. In fiscal 2020 it was $20.43M — up 1328% over 5 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2021: up 143%, from $20.43M to $49.59M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $291.85M |
| 2024ended Dec 31, 2024 | $203.07M |
| 2023ended Dec 31, 2023 | $163.91M |
| 2022ended Dec 31, 2022 | $110.25M |
| 2021ended Dec 31, 2021 | $49.59M |
| 2020ended Dec 31, 2020 | $20.43M |
Fiscal years as XERIS BIOPHARMA HOLDINGS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on XERIS BIOPHARMA HOLDINGS, INC.
- The profitability of XERIS BIOPHARMA HOLDINGS, INC.
- The cash flow of XERIS BIOPHARMA HOLDINGS, INC.
- The debt of XERIS BIOPHARMA HOLDINGS, INC.
- All of XERIS BIOPHARMA HOLDINGS, INC.'s financials, charted
Companies of a similar size
- VCELVERICEL CORPORATION
- BANCBANC OF CALIFORNIA, INC.
- DRHDIAMONDROCK HOSPITALITY CO
- CIFRCipher Digital Inc.
- ATRCAtriCure, Inc.
Not investment advice. This page shows what XERIS BIOPHARMA HOLDINGS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.